Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study

Boehringer Ingelheim

Status: Completed

Conditions: Osteoarthritis

Study type: Observational

Funder types: Industry

Identifiers

NCT02195505

1139.1

Details and patient eligibility

About

The USAGE study aims at assessing on a long-term period (two years in average) the outcome in clinical or economical term of patients with knee osteoarthritis (OA) treated or not with Synvisc®, in the 1139.4 clinical trial.

Enrollment: 374 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients have already been followed up on a nine-month period in a pragmatic medica-economical clinical trial (BI Trial No.: 1139.4)

Exclusion criteria

• none

Trial design

374 participants in 2 patient groups

Synvisc®

Usual treatment of knee

Description:

nonsteroidal antiinflammatory drugs, antalgics